Jonathan Rigby is the founder of Immune Regulation. Immune Regulation has raised $53M in total funding. Latest round: Series B. Based in Boston, MA.
Jonathan Rigby is the Group CEO of Revolo Biotherapeutics, a clinical-stage biotechnology company. He was the first employee in the U.S. for the company and led the closing of a $53.4 million Series B financing round in September 2020. Rigby also serves on the Board of Directors of IM Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library